Nathaniel Calloway SEC EDGAR Filings (CIK 0001952771)

SEC EDGAR filings, ownership reports, and insider transactions for Nathaniel Calloway.

Business address
C/O Anebulo Pharmaceuticals, Inc., 1415 Ranch Road 620 South, Suite 201, Lakeway, TX, 78734
Top holdings (ownership)
LFCR
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Nathaniel Calloway has filed 11 SEC EDGAR filings since 02 Nov 2022

Latest Filings

Recent SEC filings for Nathaniel Calloway including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 07 Apr 2025 04 Apr 2025 001-40388
4 Open 4 document View SEC filing for 4 FORM 4 10 Jul 2024 08 Jul 2024 000-27446
4 Open 4 document View SEC filing for 4 17 Jun 2024 13 Jun 2024 001-40388
4 Open 4 document View SEC filing for 4 FORM 4 02 Feb 2024 01 Feb 2024 000-27446
4 Open 4 document View SEC filing for 4 FORM 4 10 Jan 2024 09 Jan 2024 000-27446
4 Open 4 document View SEC filing for 4 FORM 4 05 Jun 2023 01 Jun 2023 000-27446
4 Open 4 document View SEC filing for 4 FORM 4 02 Feb 2023 01 Feb 2023 000-27446
4 Open 4 document View SEC filing for 4 FORM 4 11 Jan 2023 09 Jan 2023 000-27446
3 Open 3 document View SEC filing for 3 FORM 3 11 Jan 2023 09 Jan 2023 000-27446
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 Nov 2022 01 Nov 2022 001-40388
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 02 Nov 2022 28 Oct 2022 001-40388

About this filer

Nathaniel Calloway files with the SEC under CIK 0001952771. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages